Tag

Institute of Biosciences and Technology

International leader in precision medicine to join Texas A&M through Governor’s University Research Initiative

January 29, 2019
Kenneth Ramos named executive director of Institute of Biosciences and Technology, assistant vice chancellor for health services

TRIM(ming) away proteins to curtail breast cancer

January 29, 2019
Discovery of new molecular targets to stop cancer cell metastasis

Bacteria actively drive development of colorectal cancer

July 13, 2017
Texas A&M findings could help pave the way to new treatment strategies

Harnessing a cell’s own ‘self-eating’ behavior to fight cancer

November 14, 2016
How autophagy may be the key to preventing illness and even increasing lifespan

Understanding anthrax: How it can evade the immune system

August 22, 2016
Texas A&M researchers work to better understand how this wily bacterium can persist in our lungs…and what we can do to stop it

Texas A&M spin-off, Pulmotect, Inc., receives $3 million NIH grant to fund infection prevention drug trials

May 26, 2015

Clinical-stage biotechnology company Pulmotect, Inc., has been awarded a $3 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) to evaluate the safety and effectiveness of PUL-042, an inhaled therapeutic designed to prevent and treat respiratory infections in cancer patients with compromised immune systems.

Center for Epigenetics and Disease Prevention receives Texas A&M Board of Regents stamp of approval

May 1, 2015

The Texas A&M University System Board of Regents has officially approved establishment of the Texas A&M Center for Epigenetics and Disease Prevention as an organizational unit under the Texas A&M Health Science Center Institute of Biosciences and Technology. The formal recognition will play a large role in the two-year-old center’s future growth as it aims to develop treatments using naturally occurring compounds to prevent and manage diseases.

Head of Texas A&M IBT Earns Coveted Award from Sigma Xi

April 29, 2015

Cheryl Lyn Walker, Ph.D., Welch Chair of Chemistry and director of the Texas A&M Institute of Biosciences and Technology, was recently named Outstanding Distinguished Scientist for 2015 by the Texas A&M University Chapter of Sigma Xi. The coveted award is bestowed upon one scientist each year who exhibits exemplary accomplishments in science and engineering.

Texas A&M Institute of Biosciences and Technology joins Gulf Coast Consortia, further propels team science across Texas Medical Center

March 4, 2015

The Texas A&M Health Science Center Institute of Biosciences and Technology in Houston has been named the newest member of the Gulf Coast Consortia, a Houston-Galveston area organization and one of the largest inter-institutional academic cooperatives in the nation focused on building strong, collaborative, biomedical research groups and interdisciplinary training opportunities for students.

Head of Texas A&M IBT elected chair of CPRIT’s University Advisory Committee

May 15, 2014

Acknowledging the integral function of academia in the advancement of cancer research and prevention efforts across the state, the University Advisory Committee (UAC) of the Cancer Prevention and Research Institute of Texas (CPRIT) voted Cheryl Lyn Walker, Ph.D., director of the Texas A&M Health Science Center Institute of Biosciences and Technology (IBT), as chair of UAC.